The Cardiopulmonary Crisis: Pathophysiology of Pulmonary Hypertension
Pulmonary hypertension (PH) is not simply high blood pressure in the lungs; it is a complex, progressive, and often fatal remodeling of the pulmonary vascular bed that ultimately destroys the right ventricle of the heart. Diagnosing and treating PH requires a profound understanding of the delicate hemodynamic balance between the lungs and the heart. Pathophysiology of Pulmonary Hypertension is the definitive, fiercely clinical treatise on this devastating disease process. This volume provides the exact blueprints required to understand the genetic, molecular, and hemodynamic drivers of PH, ensuring clinicians can accurately classify and target the disease.
Mastering Vascular Remodeling and Right Heart Failure
The core philosophy of this text is connecting molecular dysfunction to macroscopic organ failure. The authors aggressively detail the endothelial dysfunction that initiates the disease, dictating exactly how the imbalance between vasodilators (nitric oxide, prostacyclin) and vasoconstrictors (endothelin-1) leads to smooth muscle proliferation and irreversible vessel obliteration. It provides the crucial pathophysiological framework for understanding cor pulmonale—the inevitable right ventricular hypertrophy and failure that occurs as the heart pumps against impossible resistance.
Navigating the WHO Classifications and Targeted Therapies
The book provides a masterclass in clinical classification. It dictates the exact clinical pathways for differentiating between Group 1 Pulmonary Arterial Hypertension (PAH), Group 2 (left heart disease), and Group 3 (chronic lung disease), which is absolutely critical because treatments for one group can be lethal for another. It provides exhaustive reviews of the pharmacological targets currently utilized in advanced PAH therapies, including endothelin receptor antagonists and phosphodiesterase-5 inhibitors.
Frequently Asked Questions (FAQs)
Does this book cover the genetic basis of the disease?
Yes, it features critical sections on heritable PAH, specifically detailing the BMPR2 gene mutations and their role in disrupting normal pulmonary vascular cell apoptosis.
Who is the primary audience?
It is the absolute, mandatory clinical guide for Pulmonologists, Cardiologists, Critical Care Intensivists, and Advanced Practice Nurses managing PH clinics.
